Oncogen Pharma has set-up the first Oncology API R&D Centre in the ASEAN region. In 2016, Oncogen has completed its Formulation Research and Development Centre based in Glenmarie and subsequently acquired industrial land in Bandar Enstek, Negeri Sembilan as the location for its manufacturing facility.
Malaysia was selected among many other countries due to its strategic importance in the region, ease of operations, quality of infrastructure and a talented pool of upcoming young scientists
Oncogen Pharma (Malaysia) Sdn. Bhd.